Loading candles…
Yatharth Hospital and Trauma Care Services Limited, incorporated in 2008, operates in the healthcare and hospital services industries. The company runs a network of multi-specialty and super-specialty hospitals, offering quaternary healthcare services across more than 30 specialties, including cardiology, neurosciences, oncology, and organ transplants. It serves regions such as Noida, Greater Noida, Noida Extension in Uttar Pradesh, the Delhi-NCR region, and Madhya Pradesh. Established as a hub for tertiary care, Yatharth Hospital is among the top 10 largest private healthcare providers in the Delhi-NCR region by bed capacity. Its growth strategy includes organic expansion and strategic brownfield acquisitions, with a focus on super-specialty and quaternary care services.
This page is a live market overview for YATHARTH HOSP & TRA C S L (YATHARTH) on the NSE. As a listed security, YATHARTH HOSP & TRA C S L is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for YATHARTH before placing trades on tick2trade.
As of the latest feed, YATHARTH last traded at ₹870.5 on NSE, down ₹0.95 (0.11%) from the previous close of ₹871.45. Today's session range is ₹862.9 – ₹881.9, against a 52-week band of ₹538.25 – ₹889.9. Traded volume today stands at 1.62L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for YATHARTH in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether YATHARTH is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for YATHARTH HOSP & TRA C S L before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in YATHARTH. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated YATHARTH option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Unaudited Results - FY26 | To consider and approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the period ended Jun 30, 2026, dividend and other busi… | 10 Aug 2026 |
| Audited Results - Q4 & FY26 | To consider and approve the Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Financial Year ended on March 31, 2026. | 25 May 2026 |
| Unaudited Results - Q3-FY25 | To consider and approve the Unaudited Financial Results for the quarter ended December 31, 2025 | 5 Feb 2026 |
| Unaudited Results - Q2 & FY25 | To consider and approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the second quarter and half year ended September 30, 2… | 13 Nov 2025 |
| Unaudited Results - Q1-FY25 | To consider and approve the Unaudited Financial Results for the first quarter ended June 30, 2025 | 5 Aug 2025 |
| Audited Results - Q4 & FY25 | To consider and approve the Audited Financial Results (Standalone and Consolidated) of the Company for the fourth quarter and financial year ended March 31, … | 26 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.